health
February 7, 2026
Hims & Hers pulls copycat weight-loss pill after threats of legal action
Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.
TL;DR
- Hims & Hers will no longer offer its compounded semaglutide pill.
- The decision was made after constructive conversations with industry stakeholders.
- Novo Nordisk had threatened legal action, calling the pill 'illegal mass compounding'.
- The FDA announced it planned to take legal action against Hims & Hers.
- Hims & Hers stated it has always complied with applicable law and prioritized consumer safety.
- The company plans to run an advertisement during Super Bowl 60 addressing the 'health gap'.
Continue reading the original article